Pbi66 Are Hta Agencies Buying Into the Car-T Hype?

Abstract

hospitals without rheumatology department which only use IV representing ,0,1% of DDD; 8/15 hospitals with rheumatology departments which kept IV for hospital but also started PHMEV representing 74,9% of DDD ; and 3/15 hospitals with rheumatology department which use both IV and SC at hospital also with PHMEV representing 25% of DDD. Conclusions: SC consumptions are increasing but IV still accounts for a main part. As SC and IV have close DCT and are both reimbursed in indications studied, price would not explain these differences. Different factors should be considered such as hospital policies encouraging ambulatory cares regarding day hospital capacities in every hospital and the imminent arrival of IV biosimilars.